Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
31 studies found for:    " April 23, 2008":" May 23, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" April 23, 2008":" May 23, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (31 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
2 Completed HIV Vertical Transmission in Vietnam
Condition: HIV Infections
Intervention:
3 Completed
Has Results
Qualitative Assessment of Implementing Routine Rapid HIV Testing
Condition: HIV Infections
Intervention:
4 Completed Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir/Emtricitabine
5 Completed Enhancing Communication and HIV Outcomes
Condition: HIV Infections
Intervention: Behavioral: communication training
6 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
7 Terminated Kaletra and Viread in Antiretroviral Naïve Patients
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir and tenofovir
8 Completed Preventing HIV/Aids in Drug Abusing Youth
Condition: HIV Infections
Interventions: Behavioral: IBFT /HIV prevention;   Behavioral: IBFT
9 Completed An Open Label Treatment Protocol to Provide Continued Elvucitabine Treatment
Condition: HIV Infections
Intervention: Drug: elvucitabine
10 Unknown  Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Condition: HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: Placebo
11 Completed HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
Condition: HIV Infections
Intervention: Drug: Salvage antiretroviral therapy including raltegravir
12 Completed Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Condition: HIV Infections
Intervention: Biological: AGS-004
13 Suspended Bioequivalence Study of Didanosine in Children Treated for HIV
Condition: HIV Infections
Intervention: Drug: didanosine
14 Completed Pilot Trial of a Synbiotic in HIV+ Patients
Condition: HIV Infection
Interventions: Dietary Supplement: Synbiotic 2000;   Dietary Supplement: Placebo
15 Completed Impact of Peer Health Workers and Mobile Phones on HIV Care
Condition: HIV Infections
Interventions: Behavioral: Peer Health Workers Intervention;   Behavioral: Peer Health Workers and Mobile Phone Intervention
16 Completed Rapid HIV Testing for Emergency Department Patients
Condition: HIV Infections
Intervention: Behavioral: HIV risk education
17 Completed
Has Results
Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients
Condition: HIV Infections
Intervention: Drug: raltegravir
18 Completed Neurocognitive Assessment in Youth Initiating HAART
Condition: HIV Infections
Interventions: Drug: Early Treatment with HAART;   Other: No treatment;   Drug: HAART Treatment - standard care
19 Completed Study of Provider Computer Alerts Designed to Improve Delivery of HIV Care
Condition: HIV Infections
Interventions: Other: Standard (static) Computer Alerts;   Other: Enhanced Computer Alerts
20 Completed
Has Results
Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences
Condition: HIV Infections
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.